SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
Theravance Biopharma, Inc.
@TBPH_InsiderForm 4 Filing: MITCHELL DEAN J Acquires (Grant) shares of $TBPH
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Theravance Biopharma, Inc.
Ticker: $TBPH
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-12
Shares: 6,009
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, MITCHELL DEAN J, holds the title of Director at Theravance Biopharma, Inc..
On 2026-06-12, the insider transacted 6,009 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
MITCHELL DEAN J (Director) was granted $0 of $TBPH
Post-Transaction Position: 97,213 shares
SEC Accession No: 0001199297-26-000003 (CIK: 1199297)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.